The healthcare world is witnessing a significant shift in blood sugar therapy with the emergence of GLP-1 skin applications. These patches offer a seemingly more user-friendly alternative to subcutaneous administrations of GLP-1 receptor agonists, lessening the need for daily needle sticks. The approach delivers the compound directly through the su